| 1 day | +3.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 2024-12-31 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Axel Rebien
BRD | Director/Board Member | 55 | 2020-05-31 |
Clemens Fischer
CHM | Chairman | 51 | 2020-03-03 |
| Director/Board Member | 45 | 2020-03-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-08-13 | Sell | Chairman | 1,315 | 0.0110% | ||
| 25-08-10 | Sell | Chairman | 39,678 | 0.3306% | ||
| 25-08-07 | Sell | Chairman | 873 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.13% | +3.13% | - | - | 447M | ||
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | ||
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | ||
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | ||
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | ||
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | ||
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | ||
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | ||
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | ||
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | ||
| Average | -0.49% | -3.25% | +24.40% | +55.51% | 397.1B | |
| Weighted average by Cap. | -0.56% | -2.96% | +35.28% | +81.27% |
Employees
98
Sector
Pharmaceuticals
















